Singapore Bio-Innovations was a venture capital firm run by the business development department of the Singapore government. They focus exclusively on the bio-technology industry.
20 Biopolis Way 09-01 Centros
|2008-12-18||KaloBios Pharmaceuticals||Series D||$32M||5AM Ventures, Alloy Ventures, Baxter International, EDBI, GBS Venture Partners, Lotus Biosciences, Mitsubishi Corporation Life Sciences Ventures, MPM Capital, Sanofi-Genzyme BioVentures, and Sofinnova Ventures|
|2007-07-25||KaloBios Pharmaceuticals||Series C||$20M||5AM Ventures, Alloy Ventures, EDBI, GBS Venture Partners, Lehman Brothers, Lotus Biosciences, MPM Capital, and Sofinnova Ventures|
|Five Prime Therapeutics||Other Investors||Bay Area Equity Fund, and Mitsubishi UFJ Capital|
|Kalypsys||Other Investors||Affentranger Associates, Aravis Ventures, BioVenture Fund, EDBI, Invemed Catalyst Fund, and New Leaf Venture Partners|